For Arthritis Research & Therapy's 20 year anniversary we have chosen to celebrate by commissioning seven Editorials that look back at seven original articles that we have published over the last two decades. These articles are among the most highly cited, downloaded and referenced original articles that the journal has published. We were delighted that all the original lead authors agreed to take up our challenge to look back, with hindsight at the way in which their articles have become so impactful. We wanted to let our authors be our advocates, and indeed they have done so, in a humble yet striking way.
20th Anniversary Collection
-
Citation: Arthritis Research & Therapy 2019 21:244
-
Cardiovascular disease in the QUEST-RA study, 10 years later
Citation: Arthritis Research & Therapy 2019 21:242 -
Anti-TNF-alpha-induced lupus
Citation: Arthritis Research & Therapy 2019 21:235 -
IL1 inhibition in gout—where are we a decade on?
Citation: Arthritis Research & Therapy 2019 21:233 -
High-quality cooperative research: studies that represent a triumph in the rheumatology community
Over the past 20 years, the rheumatoid arthritis (RA) treatment landscape has been continuously evolving. A range of novel biologic agents, different from the conventional therapies, became available. However,...
Citation: Arthritis Research & Therapy 2019 21:232 -
How thorough clinical observational studies on rheumatoid arthritis can have an impact on the field
Citation: Arthritis Research & Therapy 2019 21:227 -
Early rheumatoid arthritis is characterised by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin
A study by Raza et al., published in this journal in 2005, identified that RA patients, within 3 months of symptom onset, had a synovial fluid cytokine profile that was distinct from that of patients with othe...
Citation: Arthritis Research & Therapy 2019 21:226 -
Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS
A decade has passed since the publication on the comparison of the effect of adalimumab with data from a historic cohort on the progression of structural damage in the spine of patients with ankylosing spondyl...
Citation: Arthritis Research & Therapy 2019 21:225